Autonomic neuropathy in dialysis patients - investigations with a new symptom score (COMPASS 31) [0.03%]
透析患者的自主神经病变——采用新型症状评分（COMPASS-31）检查
Catharina Verena Schramm,Michael Christoph Schramm,Markus Trautner et al.
Catharina Verena Schramm et al.
Background: Symptoms of autonomic neuropathy (AN) are common in patients with diabetes and advanced renal disease. As yet different domains of autonomic neuropathy cannot be detected by a singular laboratory or invasive t...
The Leicester, Leicestershire and Rutland quality improvement project and integrated chronic kidney disease system: implementation within a primary care network [0.03%]
莱斯特、莱斯特郡和鲁特兰质量改善项目和综合慢性肾病系统：在基层医疗网络中的实施
Fahad Rizvi,Niraj Lakhani,Lydia Omuri et al.
Fahad Rizvi et al.
Background: The optimisation of patients in primary care is a prime opportunity to manage patient care within the community and reduce the burden of referrals on secondary care. This paper presents a quality improvement c...
Specific antigen-based stratification of membranous nephropathy in patients after haematopoietic stem cell allotransplantation - a case series and literature review [0.03%]
造血干细胞移植后膜性肾病的抗原谱系特征——系列病例及文献复习
Ines Bosnić Kovačić,Matija Matošević,Mario Laganović et al.
Ines Bosnić Kovačić et al.
Background: Nephrotic syndrome (NS) is a rare complication that can occur after haematopoietic stem cell transplantation (HSCT). In patients with membranous nephropathy (MN) who have undergone allogeneic HSCT, a new antig...
Guanting Chen,Yaoxian Wang,Linqi Zhang et al.
Guanting Chen et al.
MicroRNAs (miRNAs) are 18-25 nucleotides long, single-stranded, non-coding RNA molecules that regulate gene expression. They play a crucial role in maintaining normal cellular functions and homeostasis in organisms. Studies have shown that ...
A randomised, two-arm (1:1 ratio), double blind, placebo controlled phase III trial to assess the efficacy, safety, cost and cost-effectiveness of Rituximab in treating de novo or relapsing NS in patients with MCD/FSGS (TURING) [0.03%]
评估利妥昔单抗治疗MCD/FSGS新诊或复发NS患者有效性和安全性的随机、双盲、安慰剂对照III期试验(TURING研究)
Lisa C Willcocks,Wendi Qian,Ruzaika Cader et al.
Lisa C Willcocks et al.
Background: Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS) are a spectrum of disease causing the nephrotic syndrome (NS), characterised by proteinuria with debilitating oedema, as well as a hig...
Clinical Trial
BMC nephrology. 2024 Aug 7;25(1):253. DOI:10.1186/s12882-024-03576-0 2024
Correction: Prevalence and risk factors for chronic kidney disease of unknown cause in Malawi: a cross-sectional analysis in a rural and urban population [0.03%]
马拉维不明原因慢性肾脏病的患病率及危险因素：农村和城市人口横断面分析的更正结果
Sophie A Hamilton,Wisdom P Nakanga,Josephine E Prynn et al.
Sophie A Hamilton et al.
Published Erratum
BMC nephrology. 2024 Aug 5;25(1):251. DOI:10.1186/s12882-024-03681-0 2024
Kidney and cardiovascular-protective benefits of combination drug therapies in chronic kidney disease associated with type 2 diabetes [0.03%]
2型糖尿病伴慢性肾脏病的组合药物治疗的肾保护和心血管保护作用
Muhammad Shahzeb Khan,Janice P Lea
Muhammad Shahzeb Khan
Given the substantial burden of chronic kidney disease associated with type 2 diabetes, an aggressive approach to treatment is required. Despite the benefits of guideline-directed therapy, there remains a high residual risk of continuing pr...
Correction: expression and significance of Fractalkine/ CX3CL1 in MPO-AAV-associated glomerulonephritis rats [0.03%]
纠正： fractalkine / cx3cl1在MPO-AAV相关性glomerulonephritis大鼠中的表达及意义
Junxue Ma,Junjie Wang,Hongli Kang et al.
Junxue Ma et al.
Published Erratum
BMC nephrology. 2024 Aug 1;25(1):249. DOI:10.1186/s12882-024-03680-1 2024
Association between lipoprotein (a) and risk of atherosclerotic cardiovascular disease events among maintenance hemodialysis patients in Beijing, China: a single-center, retrospective study [0.03%]
中国北京维持性血液透析患者脂蛋白(a)与动脉粥样硬化性心血管病事件单中心回顾性研究
Qiaojing Liang,Guojuan Zhang,Liping Jiang
Qiaojing Liang
Background: Serum lipoprotein(a) [Lp(a)] is an independent risk factor for atherosclerotic cardiovascular disease (ASCVD) in the general population, its association with ASCVD incidence in Chinese maintenance hemodialysis...
Observational Study
BMC nephrology. 2024 Aug 1;25(1):250. DOI:10.1186/s12882-024-03690-z 2024
Hemoadsorption therapy for myoglobin removal in rhabdomyolysis: consensus of the hemoadsorption in rhabdomyolysis task force [0.03%]
横纹肌溶解症患者血肌红蛋白吸附治疗专家共识
Lui Forni,Filippo Aucella,Gabriella Bottari et al.
Lui Forni et al.
Background: Rhabdomyolysis describes a syndrome characterized by muscle necrosis and the subsequent release of creatine kinase and myoglobin into the circulation. Myoglobin elimination with extracorporeal hemoadsorption h...